Expansion & Portfolio Catalyst MedTech is expanding its nuclear cardiology and brain PET imaging portfolio, including launches like QuantumCam and a broader Digirad imaging suite, presenting opportunities to upsell refurbished equipment, modernization packages, and multi-vendor service agreements to practices and imaging centers seeking upgraded capabilities.

National Deployment With a national deployment model and long-standing Clinical Solutions experience across cardiology and neurology, there are growth opportunities to partner with large health systems and multi-site networks for standardized imaging programs, shared service contracts, and centralized maintenance.

Strategic Partnerships Recent channel and collaboration announcements with APQ Health and the Connect program indicate a push toward ecosystem partnerships, enabling sales motions around integrated solutions, extended support, and co-marketed offerings to expand reach in hospital networks and independent imaging centers.

Comprehensive Service Extensive service options, a large stock of OEM parts, and nationwide support create a compelling value proposition for customers seeking minimized downtime, predictable total cost of ownership, and attractive service-level agreements for aging SPECT, SPECT/CT, PET, and CT portfolios.

Budget & Growth Signals Revenue appears in the mid-market range with active investments in modernization and neuroimaging programs, signaling readiness from Catalyst MedTech to pursue mid- to large-size facility wins, multi-site deployments, and cross-sell of neurology brain PET, cardiac imaging, and hardware upgrades.